Texas Pharmaceuticals Private Limited, a active private limited company, was established on 19 July 2011 in Karnal, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232HR2011PTC043450. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.60 M.
Formerly known as Vivimed Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Madhu (Director), Ashok Kumar (Director), Arvind Mann (Director). Past directors included Sachin Kumar, Madhu. It holds ₹3.56 Cr open charges and ₹1.98 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at #87, Basement, Dayal Singh Colony, Karnal, Karnal, Haryana, 132001.
U24232HR2011PTC043450
043450
19 July 2011
₹1.00 Cr
₹8.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Texas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhu | Director | 16 Dec 2011 | Current |
| Ashok Kumar | Director | 08 Aug 2014 | Current |
| Arvind Mann | Director | 08 Aug 2014 | Current |
| Sachin Garg | Director | 19 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Dec 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Texas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.34% decrease. The company also saw a substantial improvement in profitability, with a 113.84% increase in profit. The company's net worth Soared by an impressive increase of 13.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Texas Pharmaceuticals had a public holding of 76.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,600,000.00
₹19,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2025 | Canara Bank | ₹4.60 M | Open |
| 11 Feb 2025 | Canara Bank | ₹6.00 M | Open |
| 08 Mar 2013 | Canara Bank | ₹2.50 Cr | Open |
| 03 Aug 2023 | Canara Bank | ₹1.30 M | Satisfied |
| 18 Nov 2016 | Canara Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Texas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Texas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Texas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Texas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
A charge registered on 03 Aug 2023 via Charge ID 100787923 with Canara Bank was fully satisfied on 15 Sep 2025. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 0.46 Cr with Charge ID 101156993 was registered on 25 Aug 2025. was documented.
Texas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
The activity A charge with Canara Bank amounted to Rs. 0.60 Cr with Charge ID 101048545 was registered on 11 Feb 2025. was completed.
A charge with Canara Bank of Rs. 2.50 Cr registered on 08 Mar 2013 with Charge ID 10457550 was modified on 30 Nov 2024. was recorded as a recent event.
The CIN of Texas Pharmaceuticals Private Limited is U24232HR2011PTC043450.
Texas Pharmaceuticals Private Limited is headquartered at #87, Basement, Dayal Singh Colony, Karnal, Karnal, Haryana, 132001.
Texas Pharmaceuticals Private Limited was incorporated on 19 July 2011.
The current directors of Texas Pharmaceuticals Private Limited are
The primary industry of Texas Pharmaceuticals Private Limited is Trade.
Texas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Texas Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.60 M.
The compliance status of Texas Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX